Laurent Humeau
Directeur Technique/Scientifique/R&D chez INOVIO PHARMACEUTICALS, INC.
Fortune : 246 412 $ au 30/04/2024
Postes actifs de Laurent Humeau
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| INOVIO PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 18/02/2014 | - |
Geneos Therapeutics, Inc.
 Geneos Therapeutics, Inc. BiotechnologyHealth Technology Geneos Therapeutics, Inc. Develops and commercializes neo-antigen based personalized cancer therapies. The firm engages in developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells. The company was founded by Niranjan Y. Sardesai in 2017 and is headquartered in Plymouth Meeting, PA. | Directeur/Membre du Conseil | 12/10/2022 | - |
Historique de carrière de Laurent Humeau
Anciens postes connus de Laurent Humeau
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| PRECIGEN, INC. | Corporate Officer/Principal | - | - |
VIRxSYS Corp.
 VIRxSYS Corp. BiotechnologyHealth Technology VIRxSYS Corp. is a holding company, which uses its proprietary platform technologies to develop therapies for serious human diseases. Its platform technologies include lentiviral vectors as a delivery vehicle for genes against certain diseases and for vaccine therapies. Its therapies are in various stages of development from pre-clinical through Phase II clinical trials. The company was founded by Boro Dropulic, William J. Turner, and Wiliam N. Sick Jr in 1998 and is headquartered in Gaithersburg, MD. | Directeur Technique/Scientifique/R&D | 01/01/2000 | - |
Formation de Laurent Humeau
Statistiques
Internationale
| Etats-Unis | 5 |
| France | 3 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
| Graduate Degree | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| INOVIO PHARMACEUTICALS, INC. | Health Technology |
| PRECIGEN, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
VIRxSYS Corp.
VIRxSYS Corp. BiotechnologyHealth Technology VIRxSYS Corp. is a holding company, which uses its proprietary platform technologies to develop therapies for serious human diseases. Its platform technologies include lentiviral vectors as a delivery vehicle for genes against certain diseases and for vaccine therapies. Its therapies are in various stages of development from pre-clinical through Phase II clinical trials. The company was founded by Boro Dropulic, William J. Turner, and Wiliam N. Sick Jr in 1998 and is headquartered in Gaithersburg, MD. | Health Technology |
| Université Paris Diderot-Paris 7 | Consumer Services |
| Université Pierre et Marie Curie | Consumer Services |
Geneos Therapeutics, Inc.
Geneos Therapeutics, Inc. BiotechnologyHealth Technology Geneos Therapeutics, Inc. Develops and commercializes neo-antigen based personalized cancer therapies. The firm engages in developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells. The company was founded by Niranjan Y. Sardesai in 2017 and is headquartered in Plymouth Meeting, PA. | Health Technology |
- Bourse
- Insiders
- Laurent Humeau
- Expérience
